Amgen Inc. Other General Expense
Amgen Inc. (AMGN) reported Other General Expense of $1.31 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2026-02-13
- Amgen Inc. other general expense for the quarter ending 2025-12-31 was $76.00M, a 24.59% increase year-over-year.
- Amgen Inc. other general expense for the quarter ending 2025-09-30 was $329.00M, a 363.38% increase year-over-year.
- Amgen Inc. other general expense for the quarter ending 2025-06-30 was $77.00M, a 600.00% increase year-over-year.
- Amgen Inc. other general expense for the quarter ending 2025-03-31 was $830.00M, a 690.48% increase year-over-year.
- Amgen Inc. other general expense for fiscal 2025 was $1.31B, a 429.03% increase from fiscal 2024.
- Amgen Inc. other general expense for fiscal 2024 was $248.00M, a 71.79% decline from fiscal 2023.
- Amgen Inc. other general expense for fiscal 2023 was $879.00M, a 74.75% increase from fiscal 2022.
- Amgen Inc. other general expense for fiscal 2022 was $503.00M, a 159.28% increase from fiscal 2021.
| Period end | Other General Expense 3 month | Other General Expense 6 month | Other General Expense 9 month | Other General Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $76.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $405.00M derived: sum of 2 quarters · filed 2026-02-13 | $482.00M derived: sum of 3 quarters · filed 2026-02-13 | $1.31B 10-K · filed 2026-02-13 |
| 2025-09-30 | $329.00M 10-Q · filed 2025-11-05 | $406.00M derived: sum of 2 quarters · filed 2025-11-05 | $1.24B 10-Q · filed 2025-11-05 | $1.30B derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $77.00M 10-Q · filed 2025-08-06 | $907.00M 10-Q · filed 2025-08-06 | $968.00M derived: sum of 3 quarters · filed 2026-02-13 | $1.04B derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $830.00M 10-Q · filed 2025-05-02 | $891.00M derived: sum of 2 quarters · filed 2026-02-13 | $962.00M derived: sum of 3 quarters · filed 2026-02-13 | $973.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $61.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $132.00M derived: sum of 2 quarters · filed 2026-02-13 | $143.00M derived: sum of 3 quarters · filed 2026-02-13 | $248.00M 10-K · filed 2026-02-13 |
| 2024-09-30 | $71.00M 10-Q · filed 2025-11-05 | $82.00M derived: sum of 2 quarters · filed 2025-11-05 | $187.00M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $11.00M 10-Q · filed 2025-08-06 | $116.00M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $105.00M 10-Q · filed 2025-05-02 | |||
| 2023-12-31 | $879.00M 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $503.00M 10-K · filed 2025-02-14 | |||
| 2021-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $43.00M derived: sum of 2 quarters · filed 2024-02-14 | $133.00M derived: sum of 3 quarters · filed 2024-02-14 | $194.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$8.00M 10-Q · filed 2021-11-03 | $82.00M derived: sum of 2 quarters · filed 2021-11-03 | $143.00M 10-Q · filed 2021-11-03 | $170.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $90.00M 10-Q · filed 2021-08-04 | $151.00M 10-Q · filed 2021-08-04 | $178.00M derived: sum of 3 quarters · filed 2023-02-09 | $179.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $61.00M 10-Q · filed 2021-04-28 | $88.00M derived: sum of 2 quarters · filed 2023-02-09 | $89.00M derived: sum of 3 quarters · filed 2023-02-09 | $225.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $28.00M derived: sum of 2 quarters · filed 2023-02-09 | $164.00M derived: sum of 3 quarters · filed 2023-02-09 | $189.00M 10-K · filed 2023-02-09 |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-03 | $137.00M derived: sum of 2 quarters · filed 2021-11-03 | $162.00M 10-Q · filed 2021-11-03 | $233.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $136.00M 10-Q · filed 2021-08-04 | $161.00M 10-Q · filed 2021-08-04 | $232.00M derived: sum of 3 quarters · filed 2022-02-16 | $233.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $25.00M 10-Q · filed 2021-04-28 | $96.00M derived: sum of 2 quarters · filed 2022-02-16 | $97.00M derived: sum of 3 quarters · filed 2022-02-16 | $94.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $72.00M derived: sum of 2 quarters · filed 2022-02-16 | $69.00M derived: sum of 3 quarters · filed 2022-02-16 | $66.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $1.00M 10-Q · filed 2020-10-29 | -$2.00M derived: sum of 2 quarters · filed 2020-10-29 | -$5.00M 10-Q · filed 2020-10-29 | $6.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | -$3.00M 10-Q · filed 2020-07-29 | -$6.00M 10-Q · filed 2020-07-29 | $5.00M derived: sum of 3 quarters · filed 2021-02-09 | $330.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$3.00M 10-Q · filed 2020-05-01 | $8.00M derived: sum of 2 quarters · filed 2021-02-09 | $333.00M derived: sum of 3 quarters · filed 2021-02-09 | $314.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $336.00M derived: sum of 2 quarters · filed 2021-02-09 | $317.00M derived: sum of 3 quarters · filed 2021-02-09 | $314.00M 10-K · filed 2021-02-09 |
| 2018-09-30 | $325.00M 10-Q · filed 2019-10-30 | $306.00M derived: sum of 2 quarters · filed 2019-10-30 | $303.00M 10-Q · filed 2019-10-30 | $331.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | -$19.00M 10-Q · filed 2019-07-31 | -$22.00M 10-Q · filed 2019-07-31 | $6.00M derived: sum of 3 quarters · filed 2020-02-12 | $303.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | -$3.00M 10-Q · filed 2019-05-01 | $25.00M derived: sum of 2 quarters · filed 2020-02-12 | $322.00M derived: sum of 3 quarters · filed 2020-02-12 | $328.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $28.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $325.00M derived: sum of 2 quarters · filed 2020-02-12 | $331.00M derived: sum of 3 quarters · filed 2020-02-12 | $375.00M 10-K · filed 2020-02-12 |
| 2017-09-30 | $297.00M 10-Q · filed 2018-10-31 | $303.00M derived: sum of 2 quarters · filed 2018-10-31 | $347.00M 10-Q · filed 2018-10-31 | $359.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $6.00M 10-Q · filed 2018-07-27 | $50.00M 10-Q · filed 2018-07-27 | $62.00M derived: sum of 3 quarters · filed 2019-02-13 | $85.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $44.00M 10-Q · filed 2018-04-25 | $56.00M derived: sum of 2 quarters · filed 2019-02-13 | $79.00M derived: sum of 3 quarters · filed 2019-02-13 | $145.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $35.00M derived: sum of 2 quarters · filed 2019-02-13 | $101.00M derived: sum of 3 quarters · filed 2019-02-13 | $133.00M 10-K · filed 2019-02-13 |
| 2016-09-30 | $23.00M 10-Q · filed 2017-10-26 | $89.00M derived: sum of 2 quarters · filed 2017-10-26 | $121.00M 10-Q · filed 2017-10-26 | $44.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $66.00M 10-Q · filed 2017-07-26 | $98.00M 10-Q · filed 2017-07-26 | $21.00M derived: sum of 3 quarters · filed 2018-02-13 | $8.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $32.00M 10-Q · filed 2017-04-27 | -$45.00M derived: sum of 2 quarters · filed 2018-02-13 | -$58.00M derived: sum of 3 quarters · filed 2018-02-13 | $23.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | -$77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$90.00M derived: sum of 2 quarters · filed 2018-02-13 | -$9.00M derived: sum of 3 quarters · filed 2018-02-13 | $49.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | -$13.00M 10-Q · filed 2016-10-28 | $68.00M derived: sum of 2 quarters · filed 2016-10-28 | $126.00M 10-Q · filed 2016-10-28 | $254.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $81.00M 10-Q · filed 2016-07-29 | $139.00M 10-Q · filed 2016-07-29 | $267.00M derived: sum of 3 quarters · filed 2017-02-14 | $533.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $58.00M 10-Q · filed 2016-05-02 | $186.00M derived: sum of 2 quarters · filed 2017-02-14 | $452.00M derived: sum of 3 quarters · filed 2017-02-14 | $495.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $128.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $394.00M derived: sum of 2 quarters · filed 2017-02-14 | $437.00M derived: sum of 3 quarters · filed 2017-02-14 | $454.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | $266.00M 10-Q · filed 2015-11-02 | $309.00M derived: sum of 2 quarters · filed 2015-11-02 | $326.00M 10-Q · filed 2015-11-02 | $351.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | $43.00M 10-Q · filed 2015-08-05 | $60.00M 10-Q · filed 2015-08-05 | $85.00M derived: sum of 3 quarters · filed 2016-10-31 | $119.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | $17.00M 10-Q · filed 2015-04-27 | $42.00M derived: sum of 2 quarters · filed 2016-10-31 | $76.00M derived: sum of 3 quarters · filed 2016-10-31 | $197.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | $25.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $59.00M derived: sum of 2 quarters · filed 2016-10-31 | $180.00M derived: sum of 3 quarters · filed 2016-10-31 | $196.00M 8-K · filed 2016-10-31 |
| 2013-09-30 | $34.00M 10-Q · filed 2014-10-29 | $155.00M derived: sum of 2 quarters · filed 2014-10-29 | $171.00M 10-Q · filed 2014-10-29 | $271.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $121.00M 10-Q · filed 2014-08-05 | $137.00M 10-Q · filed 2014-08-05 | $237.00M derived: sum of 3 quarters · filed 2015-02-19 | $347.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $16.00M 10-Q · filed 2014-04-30 | $116.00M derived: sum of 2 quarters · filed 2015-02-19 | $226.00M derived: sum of 3 quarters · filed 2015-02-19 | $305.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $210.00M derived: sum of 2 quarters · filed 2015-02-19 | $289.00M derived: sum of 3 quarters · filed 2015-02-19 | $295.00M 10-K · filed 2015-02-19 |
| 2012-09-30 | $110.00M 10-Q · filed 2013-10-29 | $189.00M derived: sum of 2 quarters · filed 2013-10-29 | $195.00M 10-Q · filed 2013-10-29 | $218.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $79.00M 10-Q · filed 2013-08-06 | $85.00M 10-Q · filed 2013-08-06 | $108.00M derived: sum of 3 quarters · filed 2014-02-24 | $962.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $6.00M 10-Q · filed 2013-05-03 | $29.00M derived: sum of 2 quarters · filed 2014-02-24 | $883.00M derived: sum of 3 quarters · filed 2014-02-24 | $886.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $877.00M derived: sum of 2 quarters · filed 2014-02-24 | $880.00M derived: sum of 3 quarters · filed 2014-02-24 | $896.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | $854.00M 10-Q · filed 2012-11-06 | $857.00M derived: sum of 2 quarters · filed 2012-11-06 | $873.00M 10-Q · filed 2012-11-06 | $991.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $3.00M 10-Q · filed 2012-08-08 | $19.00M 10-Q · filed 2012-08-08 | $137.00M derived: sum of 3 quarters · filed 2013-02-27 | $137.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $16.00M 10-Q · filed 2012-05-08 | $134.00M derived: sum of 2 quarters · filed 2013-02-27 | $134.00M derived: sum of 3 quarters · filed 2013-02-27 | $134.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $118.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $118.00M derived: sum of 2 quarters · filed 2013-02-27 | $118.00M derived: sum of 3 quarters · filed 2013-02-27 | $117.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-04 | $0.00 derived: sum of 2 quarters · filed 2011-11-04 | -$1.00M 10-Q · filed 2011-11-04 | $3.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $0.00 10-Q · filed 2011-08-08 | -$1.00M 10-Q · filed 2011-08-08 | $3.00M derived: sum of 3 quarters · filed 2012-02-29 | $12.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | -$1.00M 10-Q · filed 2011-05-10 | $3.00M derived: sum of 2 quarters · filed 2012-02-29 | $12.00M derived: sum of 3 quarters · filed 2012-02-29 | $61.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $13.00M derived: sum of 2 quarters · filed 2012-02-29 | $62.00M derived: sum of 3 quarters · filed 2012-02-29 | $67.00M 10-K · filed 2012-02-29 |
| 2009-09-30 | $9.00M 10-Q · filed 2010-11-08 | $58.00M derived: sum of 2 quarters · filed 2010-11-08 | $63.00M 10-Q · filed 2010-11-08 | $137.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $49.00M 10-Q · filed 2010-08-09 | $54.00M 10-Q · filed 2010-08-09 | $128.00M derived: sum of 3 quarters · filed 2011-02-25 | $140.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $5.00M 10-Q · filed 2010-05-07 | $79.00M derived: sum of 2 quarters · filed 2011-02-25 | $91.00M derived: sum of 3 quarters · filed 2011-02-25 | $375.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2008-12-31 | $74.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $86.00M derived: sum of 2 quarters · filed 2011-02-25 | $370.00M derived: sum of 3 quarters · filed 2011-02-25 | $380.00M 10-K · filed 2011-02-25 |
| 2008-09-30 | $12.00M 10-Q · filed 2009-11-06 | $296.00M derived: sum of 2 quarters · filed 2009-11-06 | $306.00M 10-Q · filed 2009-11-06 | |
| 2008-06-30 | $284.00M 10-Q · filed 2009-08-10 | $294.00M 10-Q · filed 2009-08-10 | ||
| 2007-12-31 | $728.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |